ORILANOLIMAB

UNII:	1LTT6HMX9N
Formula:
Preferred Substance Name:	ORILANOLIMAB
GSRS Full Record:	1LTT6HMX9N i

2066544-85-0
ALXN1830
ALXN-1830
IMMUNOGLOBULIN G4, ANTI-(HUMAN FCRN RECEPTOR) (HUMANIZED MONOCLONAL SYNT001 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL SYNT001 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IGG RECEPTOR FCRN LARGE SUBUNIT P51; SHORT=FCRN (NEONATAL FC RECEPTOR)); HUMANIZED MOUSE MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN (1-444) (VH (MUS MUSCULUS IGHV1-81*01 (93%) (IGHD)-IGHJ1*03 (92%)/HOMO SAPIENS IGHV1-18*01 (78%) (IGHD)-IGHJ6*01 (83%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(226)), CH3(K107>DEL(445))) (119-444)) (132-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV13-85*01 (88%) IGKJ2*01 (92%)/HOMO SAPIENS IGKV1-NL1*01 (83%) IGKJ4*01) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (224-224'':227-227'')-BISDISULFIDE
ORILANOLIMAB [INN]
ORILANOLIMAB [USAN]
SYNT001
SYNT-001

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ORILANOLIMAB

Synonyms and Mappings

Resources